Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice

被引:13
|
作者
Han, Xiao [1 ,2 ]
Liang, Ying [1 ,3 ]
Hempel, Briana [1 ,4 ]
Jordan, Chloe J. [1 ]
Shen, Hui [5 ]
Bi, Guo-Hua [1 ,4 ]
Li, Jin [2 ]
Xi, Zheng-Xiong [1 ]
机构
[1] Natl Inst Drug Abuse, Intramural Res Program, Mol Targets & Medicat Discovery Branch, Addict Biol Unit, Baltimore, MD 21224 USA
[2] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China
[3] Cent South Univ Forestry & Technol, Coll Food Sci & Engn, Mol Nutr Branch, Natl Engn Lab Rice & By Prod Deep Proc, Changsha 410004, Hunan, Peoples R China
[4] Natl Inst Drug Abuse, Medicat Dev Program, Intramural Res Program, Baltimore, MD 21224 USA
[5] Natl Inst Drug Abuse, Intramural Res Program, Neuroimaging Res Branch, Baltimore, MD 21224 USA
来源
JOURNAL OF NEUROSCIENCE | 2023年 / 43卷 / 03期
关键词
9-tetrahydrocannabinol; cannabinoid; CB1; receptor; dopamine neurons; aversion; anxiety; locomotion; VENTRAL TEGMENTAL AREA; INTRACRANIAL SELF-STIMULATION; ENDOCANNABINOID MODULATION; NUCLEUS-ACCUMBENS; RAT; ACTIVATION; RELEASE; DELTA(9)-TETRAHYDROCANNABINOL; LOCALIZATION; INHIBITION;
D O I
10.1523/JNEUROSCI.1493-22.2022
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cannabinoids modulate dopamine (DA) transmission and DA-related behavior, which has been thought to be mediated initially by acti-vation of cannabinoid CB1 receptors (CB1Rs) on GABA neurons. However, there is no behavioral evidence supporting it. In contrast, here we report that CB1Rs are also expressed in a subset of DA neurons and functionally underlie cannabinoid action in male and female mice. RNAscope in situ hybridization (ISH) assays demonstrated CB1 mRNA in tyrosine hydroxylase (TH)-positive DA neurons in the ventral tegmental area (VTA) and glutamate decarboxylase 1 (GAD1)-positive GABA neurons. The CB1R-expressing DA neurons were located mainly in the middle portion of the VTA with the number of CB1-TH colocalization progressively decreasing from the medial to the lateral VTA. Triple-staining assays indicated CB1R mRNA colocalization with both TH and vesicular glutamate trans-porter 2 (VgluT2, a glutamate neuronal marker) in the medial VTA close to the midline of the brain. Optogenetic activation of this population of DA neurons was rewarding as assessed by optical intracranial self-stimulation. D9-tetrahydrocannabinol (D9-THC) or ACEA (a selective CB1R agonist) dose-dependently inhibited optical intracranial self-stimulation in DAT-Cre control mice, but not in conditional knockout mice with the CB1R gene absent in DA neurons. In addition, deletion of CB1Rs from DA neurons attenuated D9-THC-induced reduction in DA release in the NAc, locomotion, and anxiety. Together, these findings indicate that CB1Rs are expressed in a subset of DA neurons that corelease DA and glutamate, and functionally underlie cannabinoid modulation of DA release and DA-related behavior.
引用
收藏
页码:373 / 385
页数:13
相关论文
共 50 条
  • [31] Neurochemical and Behavioral Effects of Cannabinoid CB1 Agonist in Male Mice
    Smith, Evan
    Alkhelb, Dalal
    Iliopoulos-Tsoutsouvas, Christos
    Nikas, Spyros
    Makriyannis, Alexandros
    Desai, Rajeev
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [32] Co-localization of neural cannabinoid CB1 receptors and GABAergic neurons in the NTS
    Brozoski, DT
    Dean, C
    Hopp, FA
    Seagard, JL
    FASEB JOURNAL, 2006, 20 (04): : A362 - A362
  • [33] Induction of Proteinuria by Cannabinoid Receptors 1 Signaling Activation in CB1 Transgenic Mice
    Hsu, Yung-Chien
    Lei, Chen-Chou
    Shih, Ya-Hsueh
    Ho, Cheng
    Lin, Chun-Liang
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 349 (02): : 162 - 168
  • [34] Effects of Cannabinoid CB1 agonists on extracellular levels of dopamine in the nucleus accumbens shell of male mice
    Smith, Evan
    Alkhelb, Dalal
    Iliopoulos-Tsoutsouvas, Christos
    Nikas, Spyros
    Desai, Rajeev
    Makriyannis, Alexandros
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [35] Opposite effects of cannabinoid CB1 and CB2 receptors on antipsychotic clozapine-induced cardiotoxicity
    Li, Liliang
    Dong, Xiaoru
    Tu, Chunyan
    Li, Xiaoqing
    Peng, Zhao
    Zhou, Yiling
    Zhang, Dingang
    Jiang, Jieqing
    Burke, Allen
    Zhao, Ziqin
    Jin, Li
    Jiang, Yan
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (07) : 890 - 905
  • [36] Delta(9)-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors
    French, ED
    NEUROSCIENCE LETTERS, 1997, 226 (03) : 159 - 162
  • [37] Investigation of CB1 cannabinoid receptors mediating antisecretory effects in rat stomach
    Adami, M
    Coruzzi, G
    Soldani, G
    Todorov, S
    Zamfirova, R
    Stavrev, E
    Brown, DR
    Kulkarni-Narla, A
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133
  • [38] Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibition
    Orio, L.
    Crespo, I.
    Lopez-Moreno, J. A.
    Reyes-Cabello, C.
    Rodriguez de Fonseca, F.
    Gomez de Heras, R.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 98 (02) : 220 - 226
  • [39] Influence of the CB1 cannabinoid receptors on the activity of the monoaminergic system in the behavioural tests in mice
    Poleszak, Ewa
    Wosko, Sylwia
    Slawinska, Karolina
    Wyska, Elzbieta
    Szopa, Aleksandra
    Doboszewska, Urszula
    Wlaz, Piotr
    Wlaz, Aleksandra
    Dudka, Jaroslaw
    Szponar, Jaroslaw
    Serefko, Anna
    BRAIN RESEARCH BULLETIN, 2019, 150 : 179 - 185
  • [40] Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors
    Redmond, William J.
    Cawston, Erin E.
    Grimsey, Natasha L.
    Stuart, Jordyn
    Edington, Amelia R.
    Glass, Michelle
    Connor, Mark
    BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (01) : 115 - 127